Eurofins Scientific SE
ERFSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,656 | $14,036 | $13,014 | $21,389 |
| - Cash | $614 | $1,221 | $487 | $515 |
| + Debt | $3,610 | $3,927 | $3,326 | $2,754 |
| Enterprise Value | $12,652 | $16,742 | $15,853 | $23,628 |
| Revenue | $6,951 | $6,515 | $6,712 | $6,718 |
| % Growth | 6.7% | -2.9% | -0.1% | – |
| Gross Profit | $4,712 | $1,375 | $4,485 | $4,568 |
| % Margin | 67.8% | 21.1% | 66.8% | 68% |
| EBITDA | $1,367 | $1,217 | $1,353 | $1,542 |
| % Margin | 19.7% | 18.7% | 20.2% | 22.9% |
| Net Income | $406 | $310 | $610 | $783 |
| % Margin | 5.8% | 4.8% | 9.1% | 11.6% |
| EPS Diluted | 2.09 | 1.3 | 3.07 | 3.9 |
| % Growth | 60.8% | -57.7% | -21.3% | – |
| Operating Cash Flow | $1,319 | $1,018 | $1,136 | $1,510 |
| Capital Expenditures | -$528 | -$550 | -$660 | -$520 |
| Free Cash Flow | $791 | $468 | $476 | $990 |